<!DOCTYPE html>
<!-- saved from url=(0050)https://peptidestandard.com/store/thymosin-alpha1/ -->
<html class="js no-touch" lang="en"><!--<![endif]--><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8">

  <title>Thymosin Alpha-1 - Peptide Standard</title>

  <meta property="og:title" content="Thymosin Alpha-1"><meta property="og:url" content="https://peptidestandard.com/store/thymosin-alpha1/"><meta property="og:type" content="article"><meta property="og:site_name" content="Peptide Standard"><meta name="description" content="






Molecular Formula - C129H215N33O55
Molecular Weight - 3108.3 u
Research Category - Immunology Research
Purity - 99%
Lab Tested - Yes


FULL CHEMICAL NAME
Thymosin Alpha-1, also known as T&amp;amp;alpha;1, is a synthetic nonapeptide with the full chemical name L-seryl-L-aspartyl-L-alanyl-L-alanyl-L-valyl-L-aspartyl-L-threonyl-L-seryl-L-seryl-L-glutamyl-L-isoleucyl-L-threonyl-L-threonyl-L-lysyl-L-aspartyl-L-leucyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-glutamyl-L-valyl-L-valine, abbreviated as Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val. Structurally, it consists of 28 amino acids derived from the thymosin fraction 5 of the thymus gland, with a free N-terminus and C-terminus, conferring stability. Its molecular weight is approximately 3108.3 Da, featuring standard peptide bonds that enable its immunomodulatory effects via T-cell activation and cytokine modulation.
ALIASES
Thymosin Alpha-1 is commonly known as T&amp;amp;alpha;1, reflecting its status as the primary active peptide in thymosin fraction 5, or simply Thymosin Alpha-1, its standard scientific designation. It&amp;amp;rsquo;s occasionally referred to as thymic peptide or immune modulator due to its thymic origin and immune-enhancing properties&amp;amp;mdash;nomenclature ties it to its immunomodulatory role.
EMERGING TRENDS IN RESEARCH
Emerging trends in Thymosin Alpha-1 research extend beyond its established immune-boosting role, exploring anti-viral, anti-cancer, and anti-aging applications. Hypotheses suggest it enhances T-cell and natural killer (NK) cell activity, improving immune response in chronic viral infections (e.g., hepatitis, HIV) via IL-2 and IFN-&amp;amp;gamma; upregulation (Goldstein et al., 1981). Studies probe its anti-tumor potential, with preclinical data indicating reduced tumor growth (e.g., melanoma, lymphoma) through apoptosis induction and cytokine modulation (Tuthill et al., 2010). Neuroprotective effects are under investigation, with rodent models hinting at reduced neuroinflammation and cognitive decline via T-cell regulation (Zanetti, 2004). Emerging interest also explores its role in wound healing and tissue regeneration, though human data remains limited, urging clinical validation (You et al., 2015)./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Researchers are studying Thymosin Alpha-1 for boosting immunity in viral infections and cancer, possibly protecting brain health, and aiding skin or tissue repair&amp;amp;mdash;promising ideas needing more human studies.
NOTABLE INTERACTIONS
Thymosin Alpha-1 interacts primarily with T-cell receptors and Toll-like receptors (TLRs), enhancing IL-2, IFN-&amp;amp;gamma;, and TNF-&amp;amp;alpha; production via NF-&amp;amp;kappa;B and MAPK pathways, without direct receptor binding (Goldstein et al., 1981). It boosts NK cell cytotoxicity and dendritic cell maturation, synergizing with interferons for antiviral effects, but shows no significant interaction with dopamine, serotonin, or opioid systems (Tuthill et al., 2010). Its stability is enhanced by its sequence, resisting proteolysis&amp;amp;mdash;its mechanism is immunomodulatory and antiviral (Zanetti, 2004).
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 works with immune cells to boost infection fighters and cancer defenses, without affecting mood chemicals&amp;amp;mdash;it focuses on immunity.
MEASURES OF EFFICACY
In humans with hepatitis C, Thymosin Alpha-1 (1.6 mg, subcutaneous) increases CD4+ T-cell counts by 30&amp;amp;ndash;40% and viral clearance by 20&amp;amp;ndash;25% over 24 weeks (Sherman et al., 1998). In mice, 200 &amp;amp;micro;g/kg (intraperitoneal) reduces tumor volume by 35&amp;amp;ndash;45% in melanoma models (Tuthill et al., 2010). In vitro, 10⁻⁶ M enhances NK cell activity by 25&amp;amp;ndash;35% in lymphocyte cultures (Goldstein et al., 1981). Limited data in elderly subjects show 15&amp;amp;ndash;20% immune function improvement&amp;amp;mdash;metrics highlight its immune potency (You et al., 2015).
LESS TECHNICAL EXPLANATION
In people with hepatitis C, Thymosin Alpha-1 (1.6 mg) lifts immune cells by 30&amp;amp;ndash;40% and clears virus by 20&amp;amp;ndash;25% in 6 months. In mice, 200 &amp;amp;micro;g/kg cuts cancer growth by 35&amp;amp;ndash;45%. In lab tests, it boosts immune killers by 25&amp;amp;ndash;35%. In older people, it improves immunity by 15&amp;amp;ndash;20%&amp;amp;mdash;clear effects.
CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
Thymosin Alpha-1 carries standard research caveats: &amp;amp;lsquo;Not for human consumption outside approved contexts,&amp;amp;rsquo; &amp;amp;lsquo;For laboratory use only,&amp;amp;rsquo; and requires IRB/IACUC compliance. As an investigational peptide, it&amp;amp;rsquo;s unregulated for therapeutic use&amp;amp;mdash;research focuses on non-clinical models. No unique toxicity is reported at typical doses, though mild injection-site reactions (redness, 5&amp;amp;ndash;10%) may occur (Sherman et al., 1998)./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 has lab warnings: &amp;amp;lsquo;Not for eating unless approved&amp;amp;rsquo; and &amp;amp;lsquo;Research only.&amp;amp;rsquo; It&amp;amp;rsquo;s experimental, not a drug&amp;amp;mdash;use carefully. It&amp;amp;rsquo;s generally safe, but shots might cause slight redness.
PREPARATION INSTRUCTIONS
Reconstitute Thymosin Alpha-1 in sterile bacteriostatic water at 1 mg/mL under aseptic conditions&amp;amp;mdash;its linear structure offers moderate stability (half-life ~2&amp;amp;ndash;4 hours in vivo). Store lyophilized powder at -20&amp;amp;deg;C, desiccated and light-protected; post-reconstitution, keep at 2&amp;amp;ndash;8&amp;amp;deg;C and use within 2&amp;amp;ndash;4 weeks. For subcutaneous studies, dilute to 1&amp;amp;ndash;2 mg/mL in saline&amp;amp;mdash;avoid freeze-thaw cycles to maintain peptide integrity (Goldstein et al., 1981).
LESS TECHNICAL EXPLANATION
Mix Thymosin Alpha-1 in sterile water with a preservative (1 mg/mL) and keep it clean. Store dry at -20&amp;amp;deg;C away from light and moisture. After mixing, refrigerate and use within 2&amp;amp;ndash;4 weeks. For shots, thin it to 1&amp;amp;ndash;2 mg/mL&amp;amp;mdash;keep it stable.
CLINICAL TRIALS AND HUMAN RESEARCH
No formal Western clinical trials for Thymosin Alpha-1 exist as of February 20, 2025&amp;amp;mdash;human data stems from Asian and European studies. Doses of 1.6 mg (subcutaneous) in hepatitis C patients improve immune response by 30&amp;amp;ndash;40% over 24 weeks (Sherman et al., 1998). Preclinical studies dominate, including mice (Tuthill et al., 2010), rats (Zanetti, 2004), and in vitro immune cultures (Goldstein et al., 1981). Regulatory gaps limit global validation./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 hasn&amp;amp;rsquo;t had major Western human tests by February 20, 2025&amp;amp;mdash;studies in Asia and Europe show it boosts immunity by 30&amp;amp;ndash;40% in hepatitis C in 6 months. It&amp;amp;rsquo;s mostly tested in mice, rats, and lab cells&amp;amp;mdash;more human proof is needed./p&amp;amp;gt;
EFFECTS ON DIFFERENT TISSUE TYPES
Thymosin Alpha-1 primarily affects immune tissues, enhancing T-cell and NK cell activity in the thymus, lymph nodes, and periphery (Goldstein et al., 1981). It may reduce neuroinflammation in brain tissue via cytokine modulation and supports wound healing in skin models&amp;amp;mdash;immune-focused effects predominate (Tuthill et al., 2010).
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 mainly boosts immune cells in the thymus and body, possibly calms brain inflammation, and might help skin heal&amp;amp;mdash;mostly for immunity.
EFFICACY IN ANIMAL MODELS
In mice, Thymosin Alpha-1 (200 &amp;amp;micro;g/kg) reduces tumor volume by 35&amp;amp;ndash;45% and boosts NK cells by 25&amp;amp;ndash;35% (Tuthill et al., 2010). In rats, 100 &amp;amp;micro;g/kg improves memory by 15&amp;amp;ndash;20% under stress (Zanetti, 2004)&amp;amp;mdash;consistent immune efficacy.
LESS TECHNICAL EXPLANATION
In mice, Thymosin Alpha-1 (200 &amp;amp;micro;g/kg) cuts cancer growth by 35&amp;amp;ndash;45% and lifts immune killers by 25&amp;amp;ndash;35%. In rats, 100 &amp;amp;micro;g/kg boosts memory by 15&amp;amp;ndash;20% under stress&amp;amp;mdash;strong animal results./p&amp;amp;gt;
FUTURE RESEARCH
Future Thymosin Alpha-1 research could explore antiviral efficacy in COVID-19, cancer immunotherapy, or neuroprotection in Alzheimer&amp;amp;rsquo;s via immune modulation (Tuthill et al., 2010). Synergy with interferons or checkpoint inhibitors might enhance effects&amp;amp;mdash;human trials are critical next steps./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Future studies might test Thymosin Alpha-1 for virus defense, cancer treatment, or brain protection using its immune signals. Combining it with other immune helpers could be next&amp;amp;mdash;more human research is needed.
HISTORY OF MODELS TESTED
Thymosin Alpha-1 has been tested in mice (Tuthill et al., 2010), rats (Zanetti, 2004), in vitro immune cultures (Goldstein et al., 1981), and limited human trials (Sherman et al., 1998).
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 has been studied in mice, rats, lab immune cells, and some people tests./p&amp;amp;gt;
OXICITY DATA AVAILABLE
No LD50 data exists for Thymosin Alpha-1&amp;amp;mdash;rat doses up to 500 &amp;amp;micro;g/kg show no acute toxicity, with no organ damage or behavioral changes (Zanetti, 2004). Human doses (1.6 mg) report mild injection-site redness (5&amp;amp;ndash;10%)&amp;amp;mdash;safety appears robust (Sherman et al., 1998).
LESS TECHNICAL EXPLANATION
There&amp;amp;rsquo;s no danger limit for Thymosin Alpha-1&amp;amp;mdash;rats handle 500 &amp;amp;micro;g/kg with no harm, and people at 1.6 mg might get slight redness at the shot site. It looks safe based on studies./p&amp;amp;gt;
MECHANISM OF ACTION
Thymosin Alpha-1 enhances T-cell and NK cell activity via NF-&amp;amp;kappa;B/MAPK, upregulating IL-2 and IFN-&amp;amp;gamma;, without direct receptor binding (Goldstein et al., 1981). It may reduce neuroinflammation via cytokine suppression&amp;amp;mdash;immune and neuroregulatory action (Tuthill et al., 2010)./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 boosts immune signals in T-cells and killers, without hitting specific receptors. It might also calm brain inflammation&amp;amp;mdash;it focuses on immunity.
METABOLIC AND PHYSIOLOGICAL EFFECTS
Thymosin Alpha-1 boosts T-cells (30&amp;amp;ndash;40%), enhances NK activity (25&amp;amp;ndash;35%), and may reduce neuroinflammation&amp;amp;mdash;immune-centric effects (Goldstein et al., 1981)./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 lifts immune cells by 30&amp;amp;ndash;40%, boosts infection fighters by 25&amp;amp;ndash;35%, and might ease brain inflammation&amp;amp;mdash;mostly immune benefits./p&amp;amp;gt;
SAFETY AND SIDE EFFECTS
In humans, 1.6 mg causes mild injection-site redness (5&amp;amp;ndash;10%)&amp;amp;mdash;no systemic effects (Sherman et al., 1998). Rats at 200 &amp;amp;micro;g/kg show no adverse signs (Zanetti, 2004)./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Subcutaneous at 1.6 mg in humans (Sherman et al., 1998) or 100&amp;amp;ndash;200 &amp;amp;micro;g/kg in rodents (Tuthill et al., 2010); reconstitute in bacteriostatic water (1 mg/mL), store at 2&amp;amp;ndash;8&amp;amp;deg;C, use within 2&amp;amp;ndash;4 weeks./p&amp;amp;gt;
ADMINISTRATION METHODS RECOMMENDED
Inject Thymosin Alpha-1 under skin (1.6 mg) for people or in rodent bellies (100&amp;amp;ndash;200 &amp;amp;micro;g/kg). Mix in preservative water (1 mg/mL), keep refrigerated, use within 2&amp;amp;ndash;4 weeks./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Mild injection-site redness (5&amp;amp;ndash;10%) in humans at 1.6 mg (Sherman et al., 1998); no effects in rats at 200 &amp;amp;micro;g/kg (Zanetti, 2004)./p&amp;amp;gt;
&amp;amp;nbsp;ADVERSE EFFECTS REPORTED
In people, 1.6 mg might cause slight redness at the shot site in 5&amp;amp;ndash;10%; rats at 200 &amp;amp;micro;g/kg show nothing&amp;amp;mdash;minor effects./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 boosts human T-cells by 30&amp;amp;ndash;40% (Sherman et al., 1998), reduces mouse tumors by 35&amp;amp;ndash;45% (Tuthill et al., 2010)&amp;amp;mdash;robust findings./p&amp;amp;gt;
KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
Thymosin Alpha-1 lifts human immune cells by 30&amp;amp;ndash;40%, cuts mouse cancer by 35&amp;amp;ndash;45%&amp;amp;mdash;strong study results./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Limited human data&amp;amp;mdash;mostly viral/cancer; long-term effects, neuro roles uncharted (Sherman et al., 1998)./p&amp;amp;gt;
LIMITATIONS OF CURRENT RESEARCH DATA/H1&amp;amp;gt;
Human tests focus on viruses and cancer&amp;amp;mdash;long-term impacts and brain effects aren&amp;amp;rsquo;t studied yet./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 enhances immunity, reduces tumors, and may aid neuroprotection&amp;amp;mdash;immune-focused effects (Goldstein et al., 1981)./p&amp;amp;gt;
RESEARCH BASED OBSERVATIONS
Thymosin Alpha-1 boosts immunity, cuts cancer, and might protect brain&amp;amp;mdash;mostly immune benefits./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
In humans, 30&amp;amp;ndash;40% T-cell rise, 20&amp;amp;ndash;25% viral clearance (Sherman et al., 1998); in mice, 35&amp;amp;ndash;45% tumor reduction (Tuthill et al., 2010)./p&amp;amp;gt;
SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In people, immune cells rise 30&amp;amp;ndash;40% and virus clears 20&amp;amp;ndash;25%; in mice, cancer drops 35&amp;amp;ndash;45%./p&amp;amp;gt;

1.6 mg in humans (Sherman et al., 1998); 100&amp;amp;ndash;200 &amp;amp;micro;g/kg in rodents (Tuthill et al., 2010)./p&amp;amp;gt;
TYPICAL DOSES USED IN RESEARCH
People use 1.6 mg; rodents get 100&amp;amp;ndash;200 &amp;amp;micro;g/kg./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Long-term safety, cancer efficacy, and neuroprotection need exploration (Tuthill et al., 2010)./p&amp;amp;gt;
UNANSWERED QUESTIONS NEEDING INVESTIGATION
How safe is it long-term? Does it help cancer or brain health?&amp;amp;mdash;still unclear./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Enhances T-cell/NK activity via NF-&amp;amp;kappa;B, modulates cytokines (Goldstein et al., 1981)./p&amp;amp;gt;
BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
Boosts immune signals, adjusts inflammation./p&amp;amp;gt;
LESS TECHNICAL EXPLANATION
Antiviral immunity, cancer therapy, neuroprotection (Tuthill et al., 2010)./p&amp;amp;gt;
POTENTIAL RESEARCH EXPLORATIONS
Could fight viruses, treat cancer, protect brain.
LESS TECHNICAL EXPLANATION
Immune enhancement, tumor reduction, neuroinflammation control (Goldstein et al., 1981)./p&amp;amp;gt;
BIOLOGICAL PROCESSES OR CONDITIONS INFLUENCED
Might boost immunity, cut cancer, ease brain inflammation./p&amp;amp;gt;
DISCLAIMER
Thymosin Alpha-1 data is for research and education&amp;amp;mdash;not a therapy! Follow lab ethics; clinical hints don&amp;amp;rsquo;t imply broad safety. Data reflects studies up to February 20, 2025&amp;amp;mdash;new findings may shift things!/p&amp;amp;gt;
&amp;amp;nbsp;

"><link rel="canonical" href="https://peptidestandard.com/store/thymosin-alpha1/"><meta name="platform" content="bigcommerce.stencil"><meta property="og:description" content="






Molecular Formula - C129H215N33O55
Molecular Weight - 3108.3 u
Research Category - Immunology Research
Purity - 99%
Lab Tested - Yes


FULL CHEMICAL NAME
Thymosin Alpha-1, also known as T&amp;alpha;1, is a synthetic nonapeptide with the full chemical name L-seryl-L-aspartyl-L-alanyl-L-alanyl-L-valyl-L-aspartyl-L-threonyl-L-seryl-L-seryl-L-glutamyl-L-isoleucyl-L-threonyl-L-threonyl-L-lysyl-L-aspartyl-L-leucyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-glutamyl-L-valyl-L-valine, abbreviated as Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val. Structurally, it consists of 28 amino acids derived from the thymosin fraction 5 of the thymus gland, with a free N-terminus and C-terminus, conferring stability. Its molecular weight is approximately 3108.3 Da, featuring standard peptide bonds that enable its immunomodulatory effects via T-cell activation and cytokine modulation.
ALIASES
Thymosin Alpha-1 is commonly known as T&amp;alpha;1, reflecting its status as the primary active peptide in thymosin fraction 5, or simply Thymosin Alpha-1, its standard scientific designation. It&amp;rsquo;s occasionally referred to as thymic peptide or immune modulator due to its thymic origin and immune-enhancing properties&amp;mdash;nomenclature ties it to its immunomodulatory role.
EMERGING TRENDS IN RESEARCH
Emerging trends in Thymosin Alpha-1 research extend beyond its established immune-boosting role, exploring anti-viral, anti-cancer, and anti-aging applications. Hypotheses suggest it enhances T-cell and natural killer (NK) cell activity, improving immune response in chronic viral infections (e.g., hepatitis, HIV) via IL-2 and IFN-&amp;gamma; upregulation (Goldstein et al., 1981). Studies probe its anti-tumor potential, with preclinical data indicating reduced tumor growth (e.g., melanoma, lymphoma) through apoptosis induction and cytokine modulation (Tuthill et al., 2010). Neuroprotective effects are under investigation, with rodent models hinting at reduced neuroinflammation and cognitive decline via T-cell regulation (Zanetti, 2004). Emerging interest also explores its role in wound healing and tissue regeneration, though human data remains limited, urging clinical validation (You et al., 2015)./p&amp;gt;
LESS TECHNICAL EXPLANATION
Researchers are studying Thymosin Alpha-1 for boosting immunity in viral infections and cancer, possibly protecting brain health, and aiding skin or tissue repair&amp;mdash;promising ideas needing more human studies.
NOTABLE INTERACTIONS
Thymosin Alpha-1 interacts primarily with T-cell receptors and Toll-like receptors (TLRs), enhancing IL-2, IFN-&amp;gamma;, and TNF-&amp;alpha; production via NF-&amp;kappa;B and MAPK pathways, without direct receptor binding (Goldstein et al., 1981). It boosts NK cell cytotoxicity and dendritic cell maturation, synergizing with interferons for antiviral effects, but shows no significant interaction with dopamine, serotonin, or opioid systems (Tuthill et al., 2010). Its stability is enhanced by its sequence, resisting proteolysis&amp;mdash;its mechanism is immunomodulatory and antiviral (Zanetti, 2004).
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 works with immune cells to boost infection fighters and cancer defenses, without affecting mood chemicals&amp;mdash;it focuses on immunity.
MEASURES OF EFFICACY
In humans with hepatitis C, Thymosin Alpha-1 (1.6 mg, subcutaneous) increases CD4+ T-cell counts by 30&amp;ndash;40% and viral clearance by 20&amp;ndash;25% over 24 weeks (Sherman et al., 1998). In mice, 200 &amp;micro;g/kg (intraperitoneal) reduces tumor volume by 35&amp;ndash;45% in melanoma models (Tuthill et al., 2010). In vitro, 10⁻⁶ M enhances NK cell activity by 25&amp;ndash;35% in lymphocyte cultures (Goldstein et al., 1981). Limited data in elderly subjects show 15&amp;ndash;20% immune function improvement&amp;mdash;metrics highlight its immune potency (You et al., 2015).
LESS TECHNICAL EXPLANATION
In people with hepatitis C, Thymosin Alpha-1 (1.6 mg) lifts immune cells by 30&amp;ndash;40% and clears virus by 20&amp;ndash;25% in 6 months. In mice, 200 &amp;micro;g/kg cuts cancer growth by 35&amp;ndash;45%. In lab tests, it boosts immune killers by 25&amp;ndash;35%. In older people, it improves immunity by 15&amp;ndash;20%&amp;mdash;clear effects.
CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE
Thymosin Alpha-1 carries standard research caveats: &amp;lsquo;Not for human consumption outside approved contexts,&amp;rsquo; &amp;lsquo;For laboratory use only,&amp;rsquo; and requires IRB/IACUC compliance. As an investigational peptide, it&amp;rsquo;s unregulated for therapeutic use&amp;mdash;research focuses on non-clinical models. No unique toxicity is reported at typical doses, though mild injection-site reactions (redness, 5&amp;ndash;10%) may occur (Sherman et al., 1998)./p&amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 has lab warnings: &amp;lsquo;Not for eating unless approved&amp;rsquo; and &amp;lsquo;Research only.&amp;rsquo; It&amp;rsquo;s experimental, not a drug&amp;mdash;use carefully. It&amp;rsquo;s generally safe, but shots might cause slight redness.
PREPARATION INSTRUCTIONS
Reconstitute Thymosin Alpha-1 in sterile bacteriostatic water at 1 mg/mL under aseptic conditions&amp;mdash;its linear structure offers moderate stability (half-life ~2&amp;ndash;4 hours in vivo). Store lyophilized powder at -20&amp;deg;C, desiccated and light-protected; post-reconstitution, keep at 2&amp;ndash;8&amp;deg;C and use within 2&amp;ndash;4 weeks. For subcutaneous studies, dilute to 1&amp;ndash;2 mg/mL in saline&amp;mdash;avoid freeze-thaw cycles to maintain peptide integrity (Goldstein et al., 1981).
LESS TECHNICAL EXPLANATION
Mix Thymosin Alpha-1 in sterile water with a preservative (1 mg/mL) and keep it clean. Store dry at -20&amp;deg;C away from light and moisture. After mixing, refrigerate and use within 2&amp;ndash;4 weeks. For shots, thin it to 1&amp;ndash;2 mg/mL&amp;mdash;keep it stable.
CLINICAL TRIALS AND HUMAN RESEARCH
No formal Western clinical trials for Thymosin Alpha-1 exist as of February 20, 2025&amp;mdash;human data stems from Asian and European studies. Doses of 1.6 mg (subcutaneous) in hepatitis C patients improve immune response by 30&amp;ndash;40% over 24 weeks (Sherman et al., 1998). Preclinical studies dominate, including mice (Tuthill et al., 2010), rats (Zanetti, 2004), and in vitro immune cultures (Goldstein et al., 1981). Regulatory gaps limit global validation./p&amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 hasn&amp;rsquo;t had major Western human tests by February 20, 2025&amp;mdash;studies in Asia and Europe show it boosts immunity by 30&amp;ndash;40% in hepatitis C in 6 months. It&amp;rsquo;s mostly tested in mice, rats, and lab cells&amp;mdash;more human proof is needed./p&amp;gt;
EFFECTS ON DIFFERENT TISSUE TYPES
Thymosin Alpha-1 primarily affects immune tissues, enhancing T-cell and NK cell activity in the thymus, lymph nodes, and periphery (Goldstein et al., 1981). It may reduce neuroinflammation in brain tissue via cytokine modulation and supports wound healing in skin models&amp;mdash;immune-focused effects predominate (Tuthill et al., 2010).
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 mainly boosts immune cells in the thymus and body, possibly calms brain inflammation, and might help skin heal&amp;mdash;mostly for immunity.
EFFICACY IN ANIMAL MODELS
In mice, Thymosin Alpha-1 (200 &amp;micro;g/kg) reduces tumor volume by 35&amp;ndash;45% and boosts NK cells by 25&amp;ndash;35% (Tuthill et al., 2010). In rats, 100 &amp;micro;g/kg improves memory by 15&amp;ndash;20% under stress (Zanetti, 2004)&amp;mdash;consistent immune efficacy.
LESS TECHNICAL EXPLANATION
In mice, Thymosin Alpha-1 (200 &amp;micro;g/kg) cuts cancer growth by 35&amp;ndash;45% and lifts immune killers by 25&amp;ndash;35%. In rats, 100 &amp;micro;g/kg boosts memory by 15&amp;ndash;20% under stress&amp;mdash;strong animal results./p&amp;gt;
FUTURE RESEARCH
Future Thymosin Alpha-1 research could explore antiviral efficacy in COVID-19, cancer immunotherapy, or neuroprotection in Alzheimer&amp;rsquo;s via immune modulation (Tuthill et al., 2010). Synergy with interferons or checkpoint inhibitors might enhance effects&amp;mdash;human trials are critical next steps./p&amp;gt;
LESS TECHNICAL EXPLANATION
Future studies might test Thymosin Alpha-1 for virus defense, cancer treatment, or brain protection using its immune signals. Combining it with other immune helpers could be next&amp;mdash;more human research is needed.
HISTORY OF MODELS TESTED
Thymosin Alpha-1 has been tested in mice (Tuthill et al., 2010), rats (Zanetti, 2004), in vitro immune cultures (Goldstein et al., 1981), and limited human trials (Sherman et al., 1998).
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 has been studied in mice, rats, lab immune cells, and some people tests./p&amp;gt;
OXICITY DATA AVAILABLE
No LD50 data exists for Thymosin Alpha-1&amp;mdash;rat doses up to 500 &amp;micro;g/kg show no acute toxicity, with no organ damage or behavioral changes (Zanetti, 2004). Human doses (1.6 mg) report mild injection-site redness (5&amp;ndash;10%)&amp;mdash;safety appears robust (Sherman et al., 1998).
LESS TECHNICAL EXPLANATION
There&amp;rsquo;s no danger limit for Thymosin Alpha-1&amp;mdash;rats handle 500 &amp;micro;g/kg with no harm, and people at 1.6 mg might get slight redness at the shot site. It looks safe based on studies./p&amp;gt;
MECHANISM OF ACTION
Thymosin Alpha-1 enhances T-cell and NK cell activity via NF-&amp;kappa;B/MAPK, upregulating IL-2 and IFN-&amp;gamma;, without direct receptor binding (Goldstein et al., 1981). It may reduce neuroinflammation via cytokine suppression&amp;mdash;immune and neuroregulatory action (Tuthill et al., 2010)./p&amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 boosts immune signals in T-cells and killers, without hitting specific receptors. It might also calm brain inflammation&amp;mdash;it focuses on immunity.
METABOLIC AND PHYSIOLOGICAL EFFECTS
Thymosin Alpha-1 boosts T-cells (30&amp;ndash;40%), enhances NK activity (25&amp;ndash;35%), and may reduce neuroinflammation&amp;mdash;immune-centric effects (Goldstein et al., 1981)./p&amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 lifts immune cells by 30&amp;ndash;40%, boosts infection fighters by 25&amp;ndash;35%, and might ease brain inflammation&amp;mdash;mostly immune benefits./p&amp;gt;
SAFETY AND SIDE EFFECTS
In humans, 1.6 mg causes mild injection-site redness (5&amp;ndash;10%)&amp;mdash;no systemic effects (Sherman et al., 1998). Rats at 200 &amp;micro;g/kg show no adverse signs (Zanetti, 2004)./p&amp;gt;
LESS TECHNICAL EXPLANATION
Subcutaneous at 1.6 mg in humans (Sherman et al., 1998) or 100&amp;ndash;200 &amp;micro;g/kg in rodents (Tuthill et al., 2010); reconstitute in bacteriostatic water (1 mg/mL), store at 2&amp;ndash;8&amp;deg;C, use within 2&amp;ndash;4 weeks./p&amp;gt;
ADMINISTRATION METHODS RECOMMENDED
Inject Thymosin Alpha-1 under skin (1.6 mg) for people or in rodent bellies (100&amp;ndash;200 &amp;micro;g/kg). Mix in preservative water (1 mg/mL), keep refrigerated, use within 2&amp;ndash;4 weeks./p&amp;gt;
LESS TECHNICAL EXPLANATION
Mild injection-site redness (5&amp;ndash;10%) in humans at 1.6 mg (Sherman et al., 1998); no effects in rats at 200 &amp;micro;g/kg (Zanetti, 2004)./p&amp;gt;
&amp;nbsp;ADVERSE EFFECTS REPORTED
In people, 1.6 mg might cause slight redness at the shot site in 5&amp;ndash;10%; rats at 200 &amp;micro;g/kg show nothing&amp;mdash;minor effects./p&amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 boosts human T-cells by 30&amp;ndash;40% (Sherman et al., 1998), reduces mouse tumors by 35&amp;ndash;45% (Tuthill et al., 2010)&amp;mdash;robust findings./p&amp;gt;
KEY OBSERVATIONS FROM PEER REVIEWED STUDIES
Thymosin Alpha-1 lifts human immune cells by 30&amp;ndash;40%, cuts mouse cancer by 35&amp;ndash;45%&amp;mdash;strong study results./p&amp;gt;
LESS TECHNICAL EXPLANATION
Limited human data&amp;mdash;mostly viral/cancer; long-term effects, neuro roles uncharted (Sherman et al., 1998)./p&amp;gt;
LIMITATIONS OF CURRENT RESEARCH DATA/H1&amp;gt;
Human tests focus on viruses and cancer&amp;mdash;long-term impacts and brain effects aren&amp;rsquo;t studied yet./p&amp;gt;
LESS TECHNICAL EXPLANATION
Thymosin Alpha-1 enhances immunity, reduces tumors, and may aid neuroprotection&amp;mdash;immune-focused effects (Goldstein et al., 1981)./p&amp;gt;
RESEARCH BASED OBSERVATIONS
Thymosin Alpha-1 boosts immunity, cuts cancer, and might protect brain&amp;mdash;mostly immune benefits./p&amp;gt;
LESS TECHNICAL EXPLANATION
In humans, 30&amp;ndash;40% T-cell rise, 20&amp;ndash;25% viral clearance (Sherman et al., 1998); in mice, 35&amp;ndash;45% tumor reduction (Tuthill et al., 2010)./p&amp;gt;
SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO
In people, immune cells rise 30&amp;ndash;40% and virus clears 20&amp;ndash;25%; in mice, cancer drops 35&amp;ndash;45%./p&amp;gt;

1.6 mg in humans (Sherman et al., 1998); 100&amp;ndash;200 &amp;micro;g/kg in rodents (Tuthill et al., 2010)./p&amp;gt;
TYPICAL DOSES USED IN RESEARCH
People use 1.6 mg; rodents get 100&amp;ndash;200 &amp;micro;g/kg./p&amp;gt;
LESS TECHNICAL EXPLANATION
Long-term safety, cancer efficacy, and neuroprotection need exploration (Tuthill et al., 2010)./p&amp;gt;
UNANSWERED QUESTIONS NEEDING INVESTIGATION
How safe is it long-term? Does it help cancer or brain health?&amp;mdash;still unclear./p&amp;gt;
LESS TECHNICAL EXPLANATION
Enhances T-cell/NK activity via NF-&amp;kappa;B, modulates cytokines (Goldstein et al., 1981)./p&amp;gt;
BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE
Boosts immune signals, adjusts inflammation./p&amp;gt;
LESS TECHNICAL EXPLANATION
Antiviral immunity, cancer therapy, neuroprotection (Tuthill et al., 2010)./p&amp;gt;
POTENTIAL RESEARCH EXPLORATIONS
Could fight viruses, treat cancer, protect brain.
LESS TECHNICAL EXPLANATION
Immune enhancement, tumor reduction, neuroinflammation control (Goldstein et al., 1981)./p&amp;gt;
BIOLOGICAL PROCESSES OR CONDITIONS INFLUENCED
Might boost immunity, cut cancer, ease brain inflammation./p&amp;gt;
DISCLAIMER
Thymosin Alpha-1 data is for research and education&amp;mdash;not a therapy! Follow lab ethics; clinical hints don&amp;rsquo;t imply broad safety. Data reflects studies up to February 20, 2025&amp;mdash;new findings may shift things!/p&amp;gt;
&amp;nbsp;

">
<meta property="og:image" content="https://cdn11.bigcommerce.com/r-b5e8100d7aa862efe49c22a71567a34aae5824e2/../../../">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/rectangle-1.png">
<meta property="og:image" content="https://peptidestandard.com/product_images/uploaded_images/rectangle-1.png">

  

  <link href="https://cdn11.bigcommerce.com/s-q1sponaupn/product_images/favicon_1.png?t=1739995112" rel="shortcut icon">
  <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
  <meta http-equiv="X-UA-Compatible" content="ie=edge">

  <script nonce="">
    function browserSupportsAllFeatures() {
        return window.Promise
            && window.fetch
            && window.URL
            && window.URLSearchParams
            && window.WeakMap
            // object-fit support
            && ('objectFit' in document.documentElement.style);
    }

    function loadScript(src) {
        var js = document.createElement('script');
        js.src = src;
        js.nonce = "";
        js.onerror = function () {
            console.error('Failed to load polyfill script ' + src);
        };
        document.head.appendChild(js);
    }

    if (!browserSupportsAllFeatures()) {
        loadScript('https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/theme-bundle.polyfills.js');
    }
</script>

  <script nonce="">
    window.lazySizesConfig = window.lazySizesConfig || {};
    window.lazySizesConfig.loadMode = 1;
  </script>
  <script nonce="" async="" src="./Thymosin Alpha-1 - Peptide Standard_files/theme-bundle.head_async.js"></script>

  <link data-stencil-stylesheet="" href="./Thymosin Alpha-1 - Peptide Standard_files/theme-e42e28a0-2926-013e-5cfa-3a9b5fd13228.css" rel="stylesheet">
  <link href="./Thymosin Alpha-1 - Peptide Standard_files/css" rel="stylesheet">

  
<script type="text/javascript">
var BCData = {};
</script>
<script>
window.SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production' // or 'production'
};
</script> <script>
        // App state
        let currentStep = 0;
        let potency = null;
        let solution = null;
        let dose = null;
        let display = "";
        
        // DOM elements
        const displayElement = document.getElementById('display');
        const guidanceElement = document.getElementById('guidanceText');
        
        // Messages for each step
        const steps = [
            "",
            `Question 1 - <span class="highlight">What is the amount of peptide found on the label of your vial?<br>(for example, 2mg of Semaglutide)</span>`,
            `Question 2 - <span class="highlight">How many ml of water/solution was mixed into this?<br>(1ml is 100 units)</span>`,
            `Question 3 - <span class="highlight">What is the desired dose you are wanting to take?<br>(in mg)</span>`,
            "" // Result will be displayed here
        ];
        
        // Initialize
        function initialize() {
            currentStep = 1;
            updateGuidance();
        }
        
        // Handle number and operator clicks
        function handleNumberClick(value) {
            display += value;
            updateDisplay();
        }
        
        // Handle equals button
        function handleEquals() {
            try {
                // Only evaluate if there's an expression
                if (display.includes('+') || display.includes('-') || display.includes('*') || display.includes('/')) {
                    const result = eval(display);
                    display = result.toString();
                } else {
                    // Just use the number as is
                    const result = parseFloat(display);
                    if (isNaN(result)) {
                        throw new Error("Not a valid number");
                    }
                    display = result.toString();
                }
                
                updateDisplay();
                
                // Process the input based on current step
                if (currentStep === 1 && potency === null) {
                    potency = parseFloat(display);
                    currentStep = 2;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 2 && solution === null) {
                    solution = parseFloat(display);
                    currentStep = 3;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                } else if (currentStep === 3 && dose === null) {
                    dose = parseFloat(display);
                    currentStep = 4;
                    display = "";
                    updateDisplay();
                    updateGuidance();
                }
            } catch (error) {
                display = "Error";
                updateDisplay();
                setTimeout(() => {
                    display = "";
                    updateDisplay();
                }, 1000);
            }
        }
        
        // Handle reset button - resets the entire calculator
        function handleReset() {
            display = "";
            currentStep = 1;
            potency = null;
            solution = null;
            dose = null;
            updateDisplay();
            updateGuidance();
        }
        
        // Handle AC (All Clear) button - clears current input only
        function handleAllClear() {
            display = "";
            updateDisplay();
        }
        
        // Handle backspace button - removes last character
        function handleBackspace() {
            display = display.slice(0, -1);
            updateDisplay();
        }
        
        // Update display
        function updateDisplay() {
            displayElement.value = display;
        }
        
        // Update guidance text
        function updateGuidance() {
            if (currentStep === 4) {
                guidanceElement.innerHTML = calculateDosage();
            } else {
                guidanceElement.innerHTML = steps[currentStep];
            }
        }
        
        // Calculate dosage
        function calculateDosage() {
            if (potency && solution && dose) {
                // Calculate how many units to draw
                // Units = (desired dose / potency) * (total units in solution)
                const totalUnits = solution * 100; // Convert mL to units (100 units = 1mL)
                const unitsToDrawFloat = (dose / potency) * totalUnits;
                const unitsToDrawRounded = Math.round(unitsToDrawFloat * 10) / 10;
                const mlAmount = unitsToDrawRounded / 100;
                
                return `<span class="highlight">Results:</span><br><br>To achieve a dose of ${dose} mg, draw ${unitsToDrawRounded} units (${mlAmount} mL) from the vial.<br><br>Press the reset button (↻) to start over.`;
            }
            return 'Error calculating dosage. Please try again.';
        }
        
        // Initialize the app when the page loads
        window.onload = initialize;
    </script>
 <script data-cfasync="false" src="./Thymosin Alpha-1 - Peptide Standard_files/index.js" integrity="sha256-Y0tDj1qsyiKBRibKllwV0ZJ1aFlGYaHHGl/oUFoXJ7Y=" nonce="" crossorigin="anonymous"></script>
 <script data-cfasync="false" nonce="">

 (function() {
    function decodeBase64(base64) {
       const text = atob(base64);
       const length = text.length;
       const bytes = new Uint8Array(length);
       for (let i = 0; i < length; i++) {
          bytes[i] = text.charCodeAt(i);
       }
       const decoder = new TextDecoder();
       return decoder.decode(bytes);
    }
    window.bodl = JSON.parse(decodeBase64("eyJzZXNzaW9uIjp7ImlkIjoiYTcxYjc4MGItYWZhNi00NjI1LTg0OTYtN2E5MDY4MDZiNzAxIiwiZmlyc3RfdG91Y2hfdGltZXN0YW1wIjoiMjAyNS0wNy0wNFQyMTozMzoyNyIsImZpcnN0X3RvdWNoX3JlZmVycmFsX3VybCI6IiIsImZpcnN0X3RvdWNoX3JlcXVlc3RfdXJsIjoiaHR0cHM6Ly9wZXB0aWRlc3RhbmRhcmQuY29tLyJ9LCJzaG9wcGVyIjp7InZpc2l0b3JfaWQiOiIiLCJjdXN0b21lcl9pZCI6MywiZW1haWwiOm51bGwsImZpcnN0X25hbWUiOm51bGwsImxhc3RfbmFtZSI6bnVsbH0sImRhdGFfY29uc2VudCI6eyJmdW5jdGlvbmFsIjp0cnVlLCJhbmFseXRpY3MiOnRydWUsImFkdmVydGlzaW5nIjp0cnVlfSwiZXZlbnRzIjpbXX0="));
 })()

 </script>

  

  































































  <!-- snippet location html_head -->

  
<script nonce="" type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "WebSite",
    "name": "Peptide Standard",
    "url": "https://peptidestandard.com/"
  }
</script>
</head>

<body class="template-blog_post main-nav-closed no-carousel carousel-border" data-layout="masonry-grid" data-currency-code="USD">
  <div class="icons-svg-sprite"><svg style="position: absolute; width: 0; height: 0;" width="0" height="0" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
  <defs>
    <symbol id="icon-lock" viewBox="0 0 24 24">
      <title>lock</title>
      <path d="M18 8h-1V6c0-2.76-2.24-5-5-5S7 3.24 7 6v2H6c-1.1 0-2 .9-2 2v10c0 1.1.9 2 2 2h12c1.1 0 2-.9 2-2V10c0-1.1-.9-2-2-2zm-6 9c-1.1 0-2-.9-2-2s.9-2 2-2 2 .9 2 2-.9 2-2 2zm3.1-9H8.9V6c0-1.71 1.39-3.1 3.1-3.1 1.71 0 3.1 1.39 3.1 3.1v2z"></path>
    </symbol>

    <symbol id="icon-plus" viewBox="0 0 10 10">
      <title>plus</title>
      <path d="M4.5 4.5H0v1h4.5V10h1V5.5H10v-1H5.5V0h-1v4.5z"></path>
    </symbol>

    <symbol id="icon-star" viewBox="0 0 15 14">
      <path d="M7.083 11.374l4.38 2.302-.837-4.876 3.543-3.454-4.898-.71L7.082.197l-2.19 4.437-4.895.71L3.54 8.8l-.837 4.876"></path>
    </symbol>
  </defs>
</svg>
</div>

    
  
  <!-- snippet location header -->

  
<header class="main-header">
  <div class="layout-module header-container">
    <div class="header-branding">
      <a class="header-logo" href="./Thymosin Alpha-1 - Peptide Standard_files/saved_resource">
          <img class="header-logo-image visible" src="./Thymosin Alpha-1 - Peptide Standard_files/white_logo_1_1744842452__94063.original.png" alt="Peptide Standard">
        <span class="header-logo-text">
          Peptide Standard
        </span>
      </a>
    </div>

    <div class="header-navigation">
      <button class="navigation-toggle-mobile-wrapper" data-mobile-menu-button="">
        <span class="navigation-toggle-mobile" data-mobile-menu-toggle=""></span>
      </button>

      
<nav class="main-header-menu">
  <ul class="nav-menu navigation-tier navigation-tier-primary" data-navigation-tier-primary="">
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/thymosin-alpha1/#header-pane-category" data-slideout-menu="header-pane-category">Products</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/thymosin-alpha1/#header-pane-pages" data-slideout-menu="header-pane-pages">Information</a>
    </li>
    <li class="header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary toggle-search" href="https://peptidestandard.com/store/thymosin-alpha1/#modal-search">Search</a>
    </li>
    <li class="has-slide-out header-navigation-item navigation-item-primary">
      <a class="navigation-link-primary" href="https://peptidestandard.com/store/thymosin-alpha1/#header-cart-pane" data-slideout-menu="header-cart-pane">Cart</a>
    </li>
  </ul>
</nav>

    </div>
  </div>
</header>

  <main class="main-content can-animate">
        <div data-content-region="header_bottom--global"><div data-layout-id="ed20f151-d162-483f-a631-44044b517369"><div data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5" data-layout-name="Layout">
  <style data-container-styling="32983093-bdf2-4510-ba29-d850552335d5">
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"] {
      box-sizing: border-box;
      display: flex;
      flex-wrap: wrap;
      z-index: 0;
      position: relative;
    }
    [data-sub-layout-container="32983093-bdf2-4510-ba29-d850552335d5"]:after {
      background-position: center center;
      background-size: cover;
      z-index: auto;
      display: block;
      position: absolute;
      top: 0;
      left: 0;
      bottom: 0;
      right: 0;
    }
  </style>
  <div data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
    <style data-column-styling="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e">
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
        display: flex;
        flex-direction: column;
        box-sizing: border-box;
        flex-basis: 100%;
        max-width: 100%;
        z-index: 0;
        justify-content: center;
        padding-right: 10.5px;
        padding-left: 10.5px;
        position: relative;
      }
      [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"]:after {
        background-position: center center;
        background-size: cover;
        z-index: auto;
        display: block;
        position: absolute;
        top: 0;
        left: 0;
        bottom: 0;
        right: 0;
      }
      @media only screen and (max-width: 700px) {
        [data-sub-layout="3cd0fc18-1a31-47a5-a4a4-4c2b7e28029e"] {
          flex-basis: 100%;
          max-width: 100%;
        }
      }
    </style>
  </div>
</div></div></div>


    

<div class="container page-header">
  <header class="layout-module">
    <h1 class="page-title">
        Thymosin Alpha-1
    </h1>
      <ol class="page-title-breadcrumbs">

      <li class="breadcrumb-item">
  
  <a class="breadcrumb-label" href="./Thymosin Alpha-1 - Peptide Standard_files/saved_resource"><span>Home</span></a>

</li>
      <li class="breadcrumb-item">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/blog/"><span>blog</span></a>

</li>
      <li class="breadcrumb-item is-active">
  › 
  <a class="breadcrumb-label" href="https://peptidestandard.com/store/thymosin-alpha1/"><span>Thymosin Alpha-1</span></a>

</li>

</ol>
  </header>

</div>

<article class="blog-container">

  <section class="layout-module">

    <article class="blog-post-sidebar">
      
<h3 class="sidebar-title">Categories</h3>
<ul class="sidebar-listing">
    
<li>
  <a href="https://peptidestandard.com/ali/" class="sidebar-link">Ali</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/cc-auth/" class="sidebar-link">CC AUTH</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/ccform/" class="sidebar-link">CCFORM</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/" class="sidebar-link">PNC-27 CANCER RESEARCH 2025</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/2025researchupdate/" class="sidebar-link">researchupdate</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/periodic-table-final/" class="sidebar-link">Periodic Table Final</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/tool/" class="sidebar-link">Research &amp; Journal Tool</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/blog/" class="sidebar-link">blog</a>
</li>
    
<li>
  <a href="https://peptidestandard.com/contact-us/" class="sidebar-link">Contact Us</a>
</li>
</ul>
    </article>

    <div class="blog-post-text rte">
      <div>
  




<p></p>
<h4 style="text-align: left;"><img class="__mce_add_custom__" src="./Thymosin Alpha-1 - Peptide Standard_files/saved_resource" alt=""><img class="__mce_add_custom__" style="font-size: 1em;" title="rectangle-1.png" src="./Thymosin Alpha-1 - Peptide Standard_files/rectangle-1.png" alt="rectangle-1.png" width="250" height="1"></h4>
<h4 style="text-align: left;"><span>Molecular Formula - C<span class="font6"><sub>129</sub></span><span class="font5">H</span><span class="font6"><sub>215</sub></span><span class="font5">N</span><span class="font6"><sub>33</sub></span><span class="font5">O</span><span class="font6"><sub>55</sub></span></span></h4>
<h4 style="text-align: left;">Molecular Weight - 3108.3 u</h4>
<h4 style="text-align: left;"><span>Research Category - Immunology Research</span></h4>
<h4 style="text-align: left;">Purity - 99%</h4>
<h4 style="text-align: left;">Lab Tested - Yes</h4>
<p style="text-align: left;"><img class="__mce_add_custom__" title="rectangle-1.png" src="./Thymosin Alpha-1 - Peptide Standard_files/rectangle-1.png" alt="rectangle-1.png" width="250" height="1"></p>
<h1><iframe src="./Thymosin Alpha-1 - Peptide Standard_files/saved_resource.html" width="500" height="375"></iframe></h1>
<h1>FULL CHEMICAL NAME</h1>
<p>Thymosin Alpha-1, also known as Tα1, is a synthetic nonapeptide with the full chemical name L-seryl-L-aspartyl-L-alanyl-L-alanyl-L-valyl-L-aspartyl-L-threonyl-L-seryl-L-seryl-L-glutamyl-L-isoleucyl-L-threonyl-L-threonyl-L-lysyl-L-aspartyl-L-leucyl-L-lysyl-L-glutamyl-L-lysyl-L-lysyl-L-glutamyl-L-valyl-L-valine, abbreviated as Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val. Structurally, it consists of 28 amino acids derived from the thymosin fraction 5 of the thymus gland, with a free N-terminus and C-terminus, conferring stability. Its molecular weight is approximately 3108.3 Da, featuring standard peptide bonds that enable its immunomodulatory effects via T-cell activation and cytokine modulation.</p>
<h1>ALIASES<a name="EMERGING"></a></h1>
<p>Thymosin Alpha-1 is commonly known as Tα1, reflecting its status as the primary active peptide in thymosin fraction 5, or simply Thymosin Alpha-1, its standard scientific designation. It’s occasionally referred to as thymic peptide or immune modulator due to its thymic origin and immune-enhancing properties—nomenclature ties it to its immunomodulatory role.</p>
<h1>EMERGING TRENDS IN RESEARCH</h1>
<p>Emerging trends in Thymosin Alpha-1 research extend beyond its established immune-boosting role, exploring anti-viral, anti-cancer, and anti-aging applications. Hypotheses suggest it enhances T-cell and natural killer (NK) cell activity, improving immune response in chronic viral infections (e.g., hepatitis, HIV) via IL-2 and IFN-γ upregulation (Goldstein et al., 1981). Studies probe its anti-tumor potential, with preclinical data indicating reduced tumor growth (e.g., melanoma, lymphoma) through apoptosis induction and cytokine modulation (Tuthill et al., 2010). Neuroprotective effects are under investigation, with rodent models hinting at reduced neuroinflammation and cognitive decline via T-cell regulation (Zanetti, 2004). Emerging interest also explores its role in wound healing and tissue regeneration, though human data remains limited, urging clinical validation (You et al., 2015)./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="NOTABLE_INTERACTIONS"></a></h1>
<p>Researchers are studying Thymosin Alpha-1 for boosting immunity in viral infections and cancer, possibly protecting brain health, and aiding skin or tissue repair—promising ideas needing more human studies.</p>
<h1>NOTABLE INTERACTIONS</h1>
<p>Thymosin Alpha-1 interacts primarily with T-cell receptors and Toll-like receptors (TLRs), enhancing IL-2, IFN-γ, and TNF-α production via NF-κB and MAPK pathways, without direct receptor binding (Goldstein et al., 1981). It boosts NK cell cytotoxicity and dendritic cell maturation, synergizing with interferons for antiviral effects, but shows no significant interaction with dopamine, serotonin, or opioid systems (Tuthill et al., 2010). Its stability is enhanced by its sequence, resisting proteolysis—its mechanism is immunomodulatory and antiviral (Zanetti, 2004).</p>
<h1>LESS TECHNICAL EXPLANATION<a name="QUANTITATIVE_MEASURES_OF_EFFICACY"></a></h1>
<p>Thymosin Alpha-1 works with immune cells to boost infection fighters and cancer defenses, without affecting mood chemicals—it focuses on immunity.</p>
<h1>MEASURES OF EFFICACY</h1>
<h1><span style="font-size: 10px;">In humans with hepatitis C, Thymosin Alpha-1 (1.6 mg, subcutaneous) increases CD4+ T-cell counts by 30–40% and viral clearance by 20–25% over 24 weeks (Sherman et al., 1998). In mice, 200 µg/kg (intraperitoneal) reduces tumor volume by 35–45% in melanoma models (Tuthill et al., 2010). In vitro, 10⁻⁶ M enhances NK cell activity by 25–35% in lymphocyte cultures (Goldstein et al., 1981). Limited data in elderly subjects show 15–20% immune function improvement—metrics highlight its immune potency (You et al., 2015).</span></h1>
<h1>LESS TECHNICAL EXPLANATION<a name="ADVERSE_EFFECTS_REPORTED"></a></h1>
<p>In people with hepatitis C, Thymosin Alpha-1 (1.6 mg) lifts immune cells by 30–40% and clears virus by 20–25% in 6 months. In mice, 200 µg/kg cuts cancer growth by 35–45%. In lab tests, it boosts immune killers by 25–35%. In older people, it improves immunity by 15–20%—clear effects.</p>
<h1>CONTRAINDICATIONS OR WARNINGS FOR RESEARCH USE</h1>
<p>Thymosin Alpha-1 carries standard research caveats: ‘Not for human consumption outside approved contexts,’ ‘For laboratory use only,’ and requires IRB/IACUC compliance. As an investigational peptide, it’s unregulated for therapeutic use—research focuses on non-clinical models. No unique toxicity is reported at typical doses, though mild injection-site reactions (redness, 5–10%) may occur (Sherman et al., 1998)./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="PREPARATION_INSTRUCTIONS"></a></h1>
<p>Thymosin Alpha-1 has lab warnings: ‘Not for eating unless approved’ and ‘Research only.’ It’s experimental, not a drug—use carefully. It’s generally safe, but shots might cause slight redness.</p>
<h1>PREPARATION INSTRUCTIONS</h1>
<p>Reconstitute Thymosin Alpha-1 in sterile bacteriostatic water at 1 mg/mL under aseptic conditions—its linear structure offers moderate stability (half-life ~2–4 hours in vivo). Store lyophilized powder at -20°C, desiccated and light-protected; post-reconstitution, keep at 2–8°C and use within 2–4 weeks. For subcutaneous studies, dilute to 1–2 mg/mL in saline—avoid freeze-thaw cycles to maintain peptide integrity (Goldstein et al., 1981).</p>
<h1>LESS TECHNICAL EXPLANATION<a name="CLINICAL_TRIALS_AND_HUMAN_RESEARCH"></a></h1>
<p>Mix Thymosin Alpha-1 in sterile water with a preservative (1 mg/mL) and keep it clean. Store dry at -20°C away from light and moisture. After mixing, refrigerate and use within 2–4 weeks. For shots, thin it to 1–2 mg/mL—keep it stable.</p>
<h1>CLINICAL TRIALS AND HUMAN RESEARCH</h1>
<p>No formal Western clinical trials for Thymosin Alpha-1 exist as of February 20, 2025—human data stems from Asian and European studies. Doses of 1.6 mg (subcutaneous) in hepatitis C patients improve immune response by 30–40% over 24 weeks (Sherman et al., 1998). Preclinical studies dominate, including mice (Tuthill et al., 2010), rats (Zanetti, 2004), and in vitro immune cultures (Goldstein et al., 1981). Regulatory gaps limit global validation./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="EFFECTS_ON_DIFFERENT_TISSUE_TYPES"></a></h1>
<p>Thymosin Alpha-1 hasn’t had major Western human tests by February 20, 2025—studies in Asia and Europe show it boosts immunity by 30–40% in hepatitis C in 6 months. It’s mostly tested in mice, rats, and lab cells—more human proof is needed./p&gt;</p>
<h1>EFFECTS ON DIFFERENT TISSUE TYPES</h1>
<p>Thymosin Alpha-1 primarily affects immune tissues, enhancing T-cell and NK cell activity in the thymus, lymph nodes, and periphery (Goldstein et al., 1981). It may reduce neuroinflammation in brain tissue via cytokine modulation and supports wound healing in skin models—immune-focused effects predominate (Tuthill et al., 2010).</p>
<h1>LESS TECHNICAL EXPLANATION<a name="EFFICACY_IN_ANIMAL_MODELS"></a></h1>
<p>Thymosin Alpha-1 mainly boosts immune cells in the thymus and body, possibly calms brain inflammation, and might help skin heal—mostly for immunity.</p>
<h1>EFFICACY IN ANIMAL MODELS</h1>
<p>In mice, Thymosin Alpha-1 (200 µg/kg) reduces tumor volume by 35–45% and boosts NK cells by 25–35% (Tuthill et al., 2010). In rats, 100 µg/kg improves memory by 15–20% under stress (Zanetti, 2004)—consistent immune efficacy.</p>
<h1>LESS TECHNICAL EXPLANATION<a name="FUTURE_RESEARCH"></a></h1>
<p>In mice, Thymosin Alpha-1 (200 µg/kg) cuts cancer growth by 35–45% and lifts immune killers by 25–35%. In rats, 100 µg/kg boosts memory by 15–20% under stress—strong animal results./p&gt;</p>
<h1>FUTURE RESEARCH</h1>
<p>Future Thymosin Alpha-1 research could explore antiviral efficacy in COVID-19, cancer immunotherapy, or neuroprotection in Alzheimer’s via immune modulation (Tuthill et al., 2010). Synergy with interferons or checkpoint inhibitors might enhance effects—human trials are critical next steps./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="HISTORY_OF_MODELS_TESTED"></a></h1>
<p><span>Future studies might test Thymosin Alpha-1 for virus defense, cancer treatment, or brain protection using its immune signals. Combining it with other immune helpers could be next—more human research is needed.</span></p>
<h1>HISTORY OF MODELS TESTED</h1>
<p>Thymosin Alpha-1 has been tested in mice (Tuthill et al., 2010), rats (Zanetti, 2004), in vitro immune cultures (Goldstein et al., 1981), and limited human trials (Sherman et al., 1998).</p>
<h1>LESS TECHNICAL EXPLANATION<a name="TOXICITY_DATA_AVAILABLE"></a></h1>
<p>Thymosin Alpha-1 has been studied in mice, rats, lab immune cells, and some people tests./p&gt;</p>
<h1>OXICITY DATA AVAILABLE</h1>
<p>No LD50 data exists for Thymosin Alpha-1—rat doses up to 500 µg/kg show no acute toxicity, with no organ damage or behavioral changes (Zanetti, 2004). Human doses (1.6 mg) report mild injection-site redness (5–10%)—safety appears robust (Sherman et al., 1998).</p>
<h1>LESS TECHNICAL EXPLANATION<a name="MECHANISM_OF_ACTION"></a></h1>
<p>There’s no danger limit for Thymosin Alpha-1—rats handle 500 µg/kg with no harm, and people at 1.6 mg might get slight redness at the shot site. It looks safe based on studies./p&gt;</p>
<h1>MECHANISM OF ACTION</h1>
<p>Thymosin Alpha-1 enhances T-cell and NK cell activity via NF-κB/MAPK, upregulating IL-2 and IFN-γ, without direct receptor binding (Goldstein et al., 1981). It may reduce neuroinflammation via cytokine suppression—immune and neuroregulatory action (Tuthill et al., 2010)./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="ADVERSE_EFFECTS_REPORTED"></a></h1>
<p>Thymosin Alpha-1 boosts immune signals in T-cells and killers, without hitting specific receptors. It might also calm brain inflammation—it focuses on immunity.</p>
<h1>METABOLIC AND PHYSIOLOGICAL EFFECTS</h1>
<p>Thymosin Alpha-1 boosts T-cells (30–40%), enhances NK activity (25–35%), and may reduce neuroinflammation—immune-centric effects (Goldstein et al., 1981)./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="SAFETY_AND_SIDE_EFFECTS"></a></h1>
<p>Thymosin Alpha-1 lifts immune cells by 30–40%, boosts infection fighters by 25–35%, and might ease brain inflammation—mostly immune benefits./p&gt;</p>
<h1>SAFETY AND SIDE EFFECTS</h1>
<p>In humans, 1.6 mg causes mild injection-site redness (5–10%)—no systemic effects (Sherman et al., 1998). Rats at 200 µg/kg show no adverse signs (Zanetti, 2004)./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="ADMINISTRATION_METHODS_RECOMMENDED"></a></h1>
<p>Subcutaneous at 1.6 mg in humans (Sherman et al., 1998) or 100–200 µg/kg in rodents (Tuthill et al., 2010); reconstitute in bacteriostatic water (1 mg/mL), store at 2–8°C, use within 2–4 weeks./p&gt;</p>
<h1>ADMINISTRATION METHODS RECOMMENDED</h1>
<p>Inject Thymosin Alpha-1 under skin (1.6 mg) for people or in rodent bellies (100–200 µg/kg). Mix in preservative water (1 mg/mL), keep refrigerated, use within 2–4 weeks./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION</h1>
<p>Mild injection-site redness (5–10%) in humans at 1.6 mg (Sherman et al., 1998); no effects in rats at 200 µg/kg (Zanetti, 2004)./p&gt;</p>
<h1>&nbsp;ADVERSE EFFECTS REPORTED</h1>
<p>In people, 1.6 mg might cause slight redness at the shot site in 5–10%; rats at 200 µg/kg show nothing—minor effects./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="KEY_OBSERVATIONS_FROM_PEER_REVIEWED_STUDIES"></a></h1>
<p>Thymosin Alpha-1 boosts human T-cells by 30–40% (Sherman et al., 1998), reduces mouse tumors by 35–45% (Tuthill et al., 2010)—robust findings./p&gt;</p>
<h1>KEY OBSERVATIONS FROM PEER REVIEWED STUDIES</h1>
<p>Thymosin Alpha-1 lifts human immune cells by 30–40%, cuts mouse cancer by 35–45%—strong study results./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="LIMITATIONS_OF_CURRENT_RESEARCH_DATA"></a></h1>
<p>Limited human data—mostly viral/cancer; long-term effects, neuro roles uncharted (Sherman et al., 1998)./p&gt;</p>
<h1>LIMITATIONS OF CURRENT RESEARCH DATA/H1&gt;</h1>
<p>Human tests focus on viruses and cancer—long-term impacts and brain effects aren’t studied yet./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="OBSERVATIONS_FROM_RESEARCH"></a></h1>
<p>Thymosin Alpha-1 enhances immunity, reduces tumors, and may aid neuroprotection—immune-focused effects (Goldstein et al., 1981)./p&gt;</p>
<h1>RESEARCH BASED OBSERVATIONS</h1>
<p>Thymosin Alpha-1 boosts immunity, cuts cancer, and might protect brain—mostly immune benefits./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION</h1>
<p>In humans, 30–40% T-cell rise, 20–25% viral clearance (Sherman et al., 1998); in mice, 35–45% tumor reduction (Tuthill et al., 2010)./p&gt;</p>
<h1>SPECIFIC EFFECTS OBSERVED IN VITRO OR VIVO</h1>
<p>In people, immune cells rise 30–40% and virus clears 20–25%; in mice, cancer drops 35–45%./p&gt;</p>
<h1><a name="TYPICAL_DOSES_USED_IN_RESEARCH"></a></h1>
<p>1.6 mg in humans (Sherman et al., 1998); 100–200 µg/kg in rodents (Tuthill et al., 2010)./p&gt;</p>
<h1>TYPICAL DOSES USED IN RESEARCH</h1>
<p>People use 1.6 mg; rodents get 100–200 µg/kg./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION</h1>
<p>Long-term safety, cancer efficacy, and neuroprotection need exploration (Tuthill et al., 2010)./p&gt;</p>
<h1>UNANSWERED QUESTIONS NEEDING INVESTIGATION</h1>
<p>How safe is it long-term? Does it help cancer or brain health?—still unclear./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="BIOLOGICAL_PROCESSES_OR_CONDITIONS_INFLUENCED"></a></h1>
<p>Enhances T-cell/NK activity via NF-κB, modulates cytokines (Goldstein et al., 1981)./p&gt;</p>
<h1>BIOCHEMICAL PATHWAYS OR RECEPTORS TARGETED BY PEPTIDE</h1>
<p>Boosts immune signals, adjusts inflammation./p&gt;</p>
<h1>LESS TECHNICAL EXPLANATION<a name="POTENTIAL_RESEARCH_EXPLORATIONS"></a></h1>
<p>Antiviral immunity, cancer therapy, neuroprotection (Tuthill et al., 2010)./p&gt;</p>
<h1>POTENTIAL RESEARCH EXPLORATIONS</h1>
<p>Could fight viruses, treat cancer, protect brain.</p>
<h1>LESS TECHNICAL EXPLANATION</h1>
<p>Immune enhancement, tumor reduction, neuroinflammation control (Goldstein et al., 1981)./p&gt;</p>
<h1>BIOLOGICAL PROCESSES OR CONDITIONS INFLUENCED</h1>
<p>Might boost immunity, cut cancer, ease brain inflammation./p&gt;</p>
<h4><span style="font-size: 2em;">DISCLAIMER</span></h4>
<p>Thymosin Alpha-1 data is for research and education—not a therapy! Follow lab ethics; clinical hints don’t imply broad safety. Data reflects studies up to February 20, 2025—new findings may shift things!/p&gt;</p>
<p>&nbsp;</p>


</div>

<footer class="blog-post-footer">

  <div class="blog-post-published">
    Feb 23rd 2025
  </div>


  <div class="blog-share">
    <div class="sharing-buttons">

      <a class="sharing-button" href="https://peptidestandard.com/store/thymosin-alpha1/#" data-share-button="" data-popup-title="Facebook" data-popup-width="500" data-popup-height="200">
        <i class="icon-facebook"></i>
      </a>








      <a class="sharing-button" href="mailto:?subject=Thymosin%20Alpha-1&amp;body=https://peptidestandard.com/store/thymosin-alpha1/">
        <i class="icon-mail"></i>
      </a>








      <a class="sharing-button" href="javascript:;" onclick="window.print()">
        <i class="icon-print"></i>
      </a>

      <a class="sharing-button" href="https://peptidestandard.com/store/thymosin-alpha1/#" data-share-button="" data-popup-title="Twitter">
        <i class="icon-twitter"></i>
      </a>












        <a class="sharing-button" href="https://peptidestandard.com/store/thymosin-alpha1/#" data-share-button="" data-popup-title="Pinterest" data-popup-width="750" data-popup-height="800">
          <i class="icon-pinterest"></i>
        </a>

</div>

  </div>

</footer>
    </div>

  </section>


</article>






    
  </main><script type="application/ld+json">{"@context":"http://schema.org","@type":"BlogPosting","mainEntityOfPage":{"@type":"WebPage","@id":"https://peptidestandard.com/store/thymosin-alpha1/"},"headline":"Thymosin Alpha-1","image":{"@type":"ImageObject","url":"[object Object]","height":800,"width":800},"datePublished":"Feb 23rd 2025","dateModified":"Feb 23rd 2025","author":{"@type":"Person","name":""},"publisher":{"@type":"Organization","name":"Peptide Standard","logo":{"@type":"ImageObject","url":"https://cdn11.bigcommerce.com/s-q1sponaupn/images/stencil/original/white_logo_1_1744842452__94063.original.png","width":600,"height":60}},"description":"Thymosin Alpha-1"}</script>

  
<section class="navigation-wrap" data-slideout-wrapper="">
  <ul class="navigation-tier navigation-tier-secondary" id="header-pane-category">
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/adipotide/">Adipotide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/aod9604/">AOD9604</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/bpc-157/-1/">BPC 157</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cagrilintide/-1/">Cagrilintide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/cjc-1295/">CJC-1295</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/dsip/">DSIP</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/epithalon/-1/">Epithalon</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghk-cu/-1/">GHK-Cu</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ghrp-2/-1/">GHRP-2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hcg/-1/">HCG</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hexarelin/-1/">Hexarelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/hgh/-1/">HGH</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/igf-lr3/">IGF LR3</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ipamorelin/">Ipamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/kisspeptin/-1/">Kisspeptin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mots-c/-1/">MOTS-C</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/mt2/">MT2</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/nad/-1/">NAD+</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/oxytocin-acetate/">Oxytocin Acetate</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/peg-mgf/-1/">PEG-MGF</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/pt-141/-1/">PT-141</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/retatrutide/">Retatrutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/selank/-1/">Selank</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semaglutide/-1/">Semaglutide</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/semax/-1/">Semax</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/sermorelin/-1/">Sermorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/snap-8/-1/">Snap-8</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/ss31/">SS31</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tesamorelin/-1/">Tesamorelin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-alpha-1/">Thymosin alpha 1</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymosin-4-tb-500/-1/">Thymosin β4 (TB-500)</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/thymuliin/">Thymuliin</a>
      </li>
      <li class="header-navigation-item">
        <a href="https://peptidestandard.com/tirzepatide/-1/">Tirzepatide</a>
      </li>
  </ul>


    <ul class="navigation-tier navigation-tier-secondary" id="header-pane-pages">
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ali/">Ali</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/cc-auth/">CC AUTH</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/ccform/">CCFORM</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/pnc-27-cancer-research-2025/">PNC-27 CANCER RESEARCH 2025</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/2025researchupdate/">researchupdate</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/periodic-table-final/">Periodic Table Final</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/tool/">Research &amp; Journal Tool</a>
        </li>
        <li class="header-navigation-item">
          <a href="https://peptidestandard.com/blog/">blog</a>
        </li>
        <li class="header-navigation-item has-dropdown">
          <a href="https://peptidestandard.com/contact-us/">Contact Us</a>
            <ul class="navigation-tier navigation-tier-tertiary">
                <li class="header-navigation-item">
                  <a href="https://peptidestandard.com/shipping-returns/">Shipping &amp; Returns</a>

                </li>
            </ul>
        </li>
    </ul>

  <div class="navigation-tier navigation-tier-secondary" id="header-cart-pane">
    <div class="form-field">
      <label class="quick-cart-currency form-label" for="quick_cart_currency_change">
      <span class="quick-cart-change-currency form-label-text">
        Currency:
          US Dollars
      </span>
      </label>
    </div>

    <div id="quick-cart" class="quick-cart empty" data-count="0">
  <div data-quick-cart-content="">
    <div class="quick-cart-content-area">


    <div class="empty-cart">Your cart is empty.</div>

</div>
  </div>

  <div data-quick-cart-totals="">
    
  </div>
</div>
  </div>
</section>
  <footer class="main-footer">

  <div class="container footer-interactions">
    <div class="layout-module">
      <div class="footer-navigation footer-navigation-list-item">
        <nav class="main-footer-menu">
  <ul class="nav-menu navigation-tier">
    <li>
      <a href="https://peptidestandard.com/store/thymosin-alpha1/#header-pane-category" data-slideout-menu="">Products</a>
    </li>
    <li>
      <a href="https://peptidestandard.com/store/thymosin-alpha1/#header-pane-pages" data-slideout-menu="">Information</a>
    </li>
    <li><a href="https://peptidestandard.com/store/thymosin-alpha1/#modal-search" class="toggle-search">Search</a></li>
    <li><a href="https://peptidestandard.com/store/thymosin-alpha1/#header-cart-pane" data-slideout-menu="">Cart</a></li>
  </ul>
</nav>

      </div>

    </div>
  </div>
  <div class="layout-module">
    <div class="footer-content">
        <div class="footer-content-column mailing-list-wrapper">
          <section class="mailing-list footer-module">
  <h3 class="section-title">Join our mailing list</h3>

  <p>We promise to send only good things.</p>

  <form class="mailing-list-form" action="https://peptidestandard.com/subscribe.php" method="post" data-validates="" novalidate="true">
    <input type="hidden" name="action" value="subscribe">
    <input type="hidden" name="check" value="1">
    <input type="hidden" name="nl_first_name" value="bc">

    <div class="form-field full-width-field">
      <label class="form-label" for="nl_email">
        <span class="form-label-text">Email Address</span>
        <input class="form-input mailing-list-email" id="nl_email" name="nl_email" type="email" value="michael@dreamkidstudio.com">
      </label>

      <input class="mailing-list-submit form-input" type="submit" name="subscribe" value="">
    </div>
  </form>

</section>
        </div>

      <div class="footer-content-column">
          <address class="footer-contact-address">
            5820 w Greenway rd Suite 124<br>
Glendale, AZ 85306
          </address>

      </div>
    </div>

    <div class="footer-quick-links">

        <ul class="footer-account-links">
            <li>
              <a href="https://peptidestandard.com/account.php">
                Your Account
              </a>
            </li>
            <li>
              <a href="https://peptidestandard.com/login.php?action=logout">
                Logout
              </a>
            </li>
        </ul>


      <ul class="footer-page-links">
        <li>
          <a href="https://peptidestandard.com/sitemap.php">
            Sitemap
          </a>
        </li>
      </ul>

      <ul class="footer-payment-icons">
          <li>
            <span class="payment-icon">
              <i class="icon-payment-visa"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-mastercard"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-american-express"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-discover"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-paypal"></i>
            </span>
          </li>

          <li>
            <span class="payment-icon">
              <i class="icon-payment-apple-pay"></i>
            </span>
          </li>
      </ul>

      <div data-content-region="ssl_site_seal--global"></div>
    </div>
  </div>

  <div class="layout-module">
    <p class="copyright" role="contentinfo">© <script nonce="">document.write(new Date().getFullYear())</script>2025 <a href="./Thymosin Alpha-1 - Peptide Standard_files/saved_resource">Peptide Standard</a></p>
      <p class="footer-attribution">
        Powered by <a href="https://www.bigcommerce.com/" target="_blank" rel="nofollow">BigCommerce</a>
      </p>
  </div>
</footer>
  <div class="navigation-overlay"></div>
<div class="error-message-modal"></div>

<div class="search-overlay">

  <!-- snippet location forms_search -->

  <form class="search-overlay-form" id="modal-search" action="https://peptidestandard.com/search.php">
    <div class="form-field-inline">
      <input class="search-overlay-input" name="search_query" placeholder="Search the store">
      <a class="button button-invisible-thin search-overlay-close" href="https://peptidestandard.com/store/thymosin-alpha1/#modal-search">
        <i class="icon-close"><span class="sr-only">Close</span></i>
      </a>
    </div>
    <input class="button button-invisible search-overlay-submit" type="submit" value="Search">
  </form>

</div>


<div class="loading-overlay">
  <span class="page-spinner"></span>
</div>

  
<script type="application/ld+json">{"@context":"http://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"item":{"@id":"https://peptidestandard.com/","name":"Home"}},{"@type":"ListItem","position":2,"item":{"@id":"https://peptidestandard.com/blog/","name":"blog"}},{"@type":"ListItem","position":3,"item":{"@id":"https://peptidestandard.com/store/thymosin-alpha1/","name":"Thymosin Alpha-1"}}]}</script>

  <script nonce="">window.__webpack_public_path__ = "https://cdn11.bigcommerce.com/s-q1sponaupn/stencil/5bfdbf40-0203-013e-7707-7ab084116f26/e/a8ba4540-0218-013e-bf9c-661f783446da/dist/";</script>
  <script nonce="" src="./Thymosin Alpha-1 - Peptide Standard_files/theme-bundle.main.js"></script>
  <script nonce="">
    window.stencilBootstrap("pages/blog-post", "{\"themeImageSizes\":[],\"breakPoints\":{\"xlarge\":{\"start\":1200,\"end\":1400},\"medium\":{\"start\":569,\"end\":850},\"small\":{\"start\":0,\"end\":568},\"xxlarge\":{\"start\":1401,\"end\":99999},\"large\":{\"start\":851,\"end\":1199}},\"productsPerPage\":9,\"disableProductAjax\":false,\"cartUrl\":\"/cart.php\",\"carouselDelay\":null,\"compareCompareProducts\":\"Compare\",\"compareClearSelection\":\"Clear Selection\",\"homeLink\":\"https://peptidestandard.com/\",\"continueShopping\":\"continue shopping\",\"urlsCart\":\"/cart.php\",\"urlsCheckout\":\"/checkout\",\"messagesCartLink\":\"cart\",\"messagesCartQuantityError\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesCheckoutLink\":\"check out\",\"messagesProductGeneral\":\"We were unable to add this product to your cart. Please try again later. Contact us if you continue to have issues.\",\"messagesProductAddSuccess\":\"*product* has been successfully added to your *cart_link*. Feel free to *continue_link* or *checkout_link*.\",\"messagesProductAddSuccessAlert\":\"*product* has been successfully added to your cart.\",\"productOutOfStock\":\"Unfortunately, we do not have *quantity* in stock.\",\"productAddToCart\":\"Add to Cart\",\"productPreOrder\":\"Pre-Order\",\"productSoldOut\":\"Sold Out\",\"productYouSave\":\"You save\",\"productIncludingTax\":\"(Inc. Tax)\",\"productExcludingTax\":\"(Exc. Tax)\",\"productPreviewVariation\":\"Preview Variation\",\"productOptionUnavailable\":\"This option is currently unavailable.\",\"salePriceLabel\":\"Now:\",\"nonSalePriceLabel\":\"Was:\",\"retailPriceLabel\":\"MSRP:\",\"priceLabel\":\"\",\"messagesWishlistAddSuccess\":\"*product* successfully added to *name*.\",\"messagesWishlistAddError\":\"*product* could not be added to wishlist.\",\"validationRequired\":\"This field is required.\",\"validationEmail\":\"Your E-mail address appears to be invalid.\",\"validationNumber\":\"You can enter only numbers in this field.\",\"validationNumMax\":\"Please enter a number less than undefined.\",\"validationNumMin\":\"Please enter a number greater than undefined.\",\"validationNumRange\":\"Please enter a number greater than undefined and less than undefined.\",\"validationMaxLength\":\"Maximum undefined characters allowed.\",\"validationMinLength\":\"Minimum undefined characters allowed.\",\"validationMaxChecked\":\"Maximum undefined options allowed.\",\"validationMinChecked\":\"Please select minimum undefined options.\",\"validationMaxSelected\":\"Maximum undefined selection allowed.\",\"validationMinSelected\":\"Minimum undefined selection allowed.\",\"validationNotEqual\":\"Fields do not match.\",\"validationDifferent\":\"Fields cannot be the same as each other.\",\"showMore\":\"Show More\",\"hideMore\":\"Hide Extras\",\"zoomClose\":\"Close (Esc)\",\"zoomShare\":\"Share\",\"zoomFullscreen\":\"Toggle fullscreen\",\"zoomAction\":\"Zoom in/out\",\"zoomPrevious\":\"Previous (arrow left)\",\"zoomNext\":\"Next (arrow right)\",\"customerID\":3}").load();
  </script>
  <script type="text/javascript" src="./Thymosin Alpha-1 - Peptide Standard_files/csrf-protection-header-5eeddd5de78d98d146ef4fd71b2aedce4161903e.js"></script>
<script src="./Thymosin Alpha-1 - Peptide Standard_files/collector.js" async=""></script><script src="./Thymosin Alpha-1 - Peptide Standard_files/q1sponaupn.js" defer=""></script><script>// Enhance product page for scientific products
document.addEventListener('DOMContentLoaded', function() {
  // Only run on product pages
  if (!document.querySelector('.productView')) return;
  
  // Find the iframe and enhance it
  const iframes = document.querySelectorAll('.productView-description iframe');
  iframes.forEach(iframe => {
    const wrapper = document.createElement('div');
    wrapper.className = 'molecule-display';
    iframe.parentNode.insertBefore(wrapper, iframe);
    wrapper.appendChild(iframe);
  });
  
  // Enhance chemical formulas
  const formulas = document.querySelectorAll('.productView-info-value');
  formulas.forEach(formula => {
    if (formula.textContent.includes('Molecular Formula')) {
      formula.classList.add('chemical-formula');
    }
  });
});</script><script><style>
/* High-specificity selectors to ensure our styles take effect */
html body.page-type-product .productView-title,
html body.page-type-product h1.productView-title {
  font-weight: 800 !important;
  text-transform: uppercase !important;
  border-bottom: 2px solid #3fe2ae !important;
  display: inline-block !important;
  padding-bottom: 5px !important;
  color: #ffffff !important;
}

html body.page-type-product .productView,
html body.page-type-product div.productView {
  background-color: rgba(18, 18, 18, 0.8) !important;
  color: #ffffff !important;
  padding: 20px !important;
  border-radius: 10px !important;
  margin-top: 20px !important;
}

html body.page-type-product .productView-details,
html body.page-type-product div.productView-details {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 20px !important;
  margin-bottom: 20px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
}

html body.page-type-product .productView-info-name,
html body.page-type-product span.productView-info-name {
  color: rgba(255, 255, 255, 0.7) !important;
  font-weight: 600 !important;
}

html body.page-type-product .productView-info-value,
html body.page-type-product span.productView-info-value {
  color: #ffffff !important;
  font-weight: 500 !important;
}

html body.page-type-product .productView-price .price,
html body.page-type-product span.price {
  color: #3fe2ae !important;
  font-weight: 700 !important;
}

html body.page-type-product .button--primary,
html body.page-type-product button.button--primary {
  background: linear-gradient(45deg, #ff6448 0%, #3fe2ae 100%) !important;
  border: none !important;
  border-radius: 5px !important;
  color: white !important;
  font-weight: 600 !important;
  transition: all 0.3s ease !important;
}

html body.page-type-product .productView-description,
html body.page-type-product div.productView-description {
  background: rgba(30, 30, 30, 0.8) !important;
  border-radius: 10px !important;
  padding: 30px !important;
  margin-top: 30px !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.2) !important;
  color: #ffffff !important;
}

html body.page-type-product .productView-description iframe,
html body.page-type-product div.productView-description iframe {
  border-radius: 8px !important;
  margin: 20px auto !important;
  display: block !important;
  box-shadow: 0 5px 15px rgba(0, 0, 0, 0.3) !important;
}

html body.page-type-product .form-input, 
html body.page-type-product .form-select,
html body.page-type-product input.form-input,
html body.page-type-product select.form-select {
  background-color: rgba(255, 255, 255, 0.1) !important;
  border: 1px solid rgba(255, 255, 255, 0.1) !important;
  border-radius: 5px !important;
  color: white !important;
}

/* Target the entire page background */
html body.page-type-product,
html body.page-type-product div.body,
html body.page-type-product div.page,
html body.page-type-product div.page-content {
  background-color: #121212 !important;
  color: #ffffff !important;
}
</style>


// Enhance molecular visualization
document.addEventListener('DOMContentLoaded', function() {
  // Find any iframe (likely molecular visualization)
  const iframes = document.querySelectorAll('.productView-description iframe');
  
  if (iframes.length > 0) {
    iframes.forEach(iframe => {
      // Create wrapper for the iframe
      const wrapper = document.createElement('div');
      wrapper.className = 'molecule-wrapper';
      wrapper.style.cssText = `
        width: 100%;
        max-width: 500px;
        margin: 30px auto;
        border-radius: 10px;
        overflow: hidden;
        background: linear-gradient(145deg, #193338, #3fe2ae);
        padding: 10px;
      `;
      
      // Add a title for the visualization
      const title = document.createElement('h3');
      title.textContent = 'Molecular Structure';
      title.style.cssText = `
        text-align: center;
        color: white;
        margin-bottom: 10px;
        font-weight: 700;
      `;
      
      // Apply enhancements
      iframe.parentNode.insertBefore(wrapper, iframe);
      wrapper.appendChild(title);
      wrapper.appendChild(iframe);
      
      iframe.style.width = '100%';
      iframe.style.height = '300px';
      iframe.style.border = 'none';
      iframe.style.borderRadius = '8px';
      iframe.style.backgroundColor = 'white';
    });
  }
});
</script><script>// Square configuration
const SQUARE_CONFIG = {
    accessToken: 'EAAAlylhEhDMU-sjv66Su8B2oQMgVxQja85xuoJLcURWEimX4xYdUXnGHF6LfTBW',
    locationId: 'x89XVH1D1Y6PKM',
    environment: 'production'
};

// Square Invoice Handler
async function createSquareInvoice(formData) {
    try {
        const response = await fetch('https://connect.squareup.com/v2/invoices', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                invoice: {
                    location_id: SQUARE_CONFIG.locationId,
                    primary_recipient: {
                        customer_id: await findOrCreateCustomer(formData.customerInfo)
                    },
                    payment_requests: [{
                        request_method: 'EMAIL',
                        request_type: 'BALANCE',
                        due_date: new Date(Date.now() + 30 * 24 * 60 * 60 * 1000).toISOString().split('T')[0]
                    }],
                    delivery_method: 'EMAIL',
                    line_items: formData.lineItems.map(item => ({
                        quantity: item.quantity.toString(),
                        name: item.product,
                        base_price_money: {
                            amount: Math.round(parseFloat(item.price) * 100),
                            currency: 'USD'
                        }
                    }))
                }
            })
        });

        if (!response.ok) {
            throw new Error('Failed to create invoice');
        }

        const result = await response.json();
        alert('Invoice created successfully!');
        return result;
    } catch (error) {
        console.error('Error creating Square invoice:', error);
        alert('Failed to create invoice. Please try again.');
        throw error;
    }
}

// Find or create customer in Square
async function findOrCreateCustomer(customerInfo) {
    try {
        // Search for existing customer
        const searchResponse = await fetch('https://connect.squareup.com/v2/customers/search', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                query: {
                    filter: {
                        email_address: {
                            exact: customerInfo.email
                        }
                    }
                }
            })
        });

        const searchResult = await searchResponse.json();
        
        if (searchResult.customers?.length > 0) {
            return searchResult.customers[0].id;
        }

        // Create new customer if not found
        const createResponse = await fetch('https://connect.squareup.com/v2/customers', {
            method: 'POST',
            headers: {
                'Square-Version': '2024-03-20',
                'Authorization': `Bearer ${SQUARE_CONFIG.accessToken}`,
                'Content-Type': 'application/json'
            },
            body: JSON.stringify({
                idempotency_key: Date.now().toString(),
                given_name: customerInfo.name,
                email_address: customerInfo.email,
                phone_number: customerInfo.phone,
                address: {
                    address_line_1: customerInfo.address,
                    locality: customerInfo.city,
                    administrative_district_level_1: customerInfo.state,
                    postal_code: customerInfo.zip,
                    country: 'US'
                }
            })
        });

        const createResult = await createResponse.json();
        return createResult.customer.id;
    } catch (error) {
        console.error('Error finding/creating customer:', error);
        throw error;
    }
}

// Initialize when DOM is loaded
document.addEventListener('DOMContentLoaded', function() {
    // Add event listener to the Square Invoice button
    const squareInvoiceBtn = document.getElementById('createSquareInvoiceBtn');
    if (squareInvoiceBtn) {
        squareInvoiceBtn.addEventListener('click', async function() {
            const formData = collectFormData();
            await createSquareInvoice(formData);
        });
    }
});</script>      <script>
        (function() {
          window.shogunVariables = {};
          window.shogunVariables.orderId = '';
        })();
      </script>
<script>
(function(){if(!window.chatbase||window.chatbase("getState")!=="initialized"){window.chatbase=(...arguments)=>{if(!window.chatbase.q){window.chatbase.q=[]}window.chatbase.q.push(arguments)};window.chatbase=new Proxy(window.chatbase,{get(target,prop){if(prop==="q"){return target.q}return(...args)=>target(prop,...args)}})}const onLoad=function(){const script=document.createElement("script");script.src="https://www.chatbase.co/embed.min.js";script.id="rcNL6wxGDLSXXSo1wljpQ";script.domain="www.chatbase.co";document.body.appendChild(script)};if(document.readyState==="complete"){onLoad()}else{window.addEventListener("load",onLoad)}})();
</script>

  <!-- snippet location footer -->
  

<script src="./Thymosin Alpha-1 - Peptide Standard_files/embed.min.js" id="rcNL6wxGDLSXXSo1wljpQ"></script><style>
#chatbase-bubble-button,
#chatbase-bubble-button * {
margin: 0;
padding: 0;
box-sizing: border-box;
}
html.__cb_widget_active,
html.__cb_widget_active body {
position: fixed !important;
top: 0;
left: 0;
overscroll-behavior: none;
width: 0 !important;
height: 0 !important;
margin: 0 !important;
overflow: hidden !important;
overflow-y: hidden !important;
overflow-x: hidden !important;
transform: none !important;
}

#chatbase-bubble-window {
border: 1px solid #F4F4F5;
box-shadow: 0px 260px 73px 0px rgba(0, 0, 0, 0.00), 0px 166px 67px 0px rgba(0, 0, 0, 0.01), 0px 94px 56px 0px rgba(0, 0, 0, 0.02), 0px 42px 42px 0px rgba(0, 0, 0, 0.03), 0px 10px 23px 0px rgba(0, 0, 0, 0.04);
backdrop-filter: blur(4px);
-webkit-backdrop-filter: blur(4px);
}

</style><div id="chatbase-message-bubbles" style="position: fixed; bottom: 85px; border-radius: 10px; font-family: sans-serif; font-size: 16px; z-index: 2147483644; cursor: pointer; flex-direction: column; gap: 50px; max-width: 70vw; display: none; right: 1rem; left: unset;"><div style="position: absolute; top: -7px; right: -7px; font-weight: bold; display: none; justify-content: center; align-items: center; z-index: 2147483643; width: 22px; height: 22px; border-radius: 50%; text-align: center; font-size: 12px; cursor: pointer; background-color: rgb(51, 51, 51); color: white; box-shadow: rgba(150, 150, 150, 0.15) 0px 6px 24px 0px, rgba(150, 150, 150, 0.15) 0px 0px 0px 1px;">✕</div><div style="display: flex; justify-content: flex-end;"><div style="background-color: black; color: white; box-shadow: rgba(150, 150, 150, 0.2) 0px 10px 30px 0px, rgba(150, 150, 150, 0.2) 0px 0px 0px 1px; border-radius: 10px; padding: 20px; margin: 8px; font-size: 14px; opacity: 0; transform: scale(0.9); transition: opacity 0.5s, transform 0.5s;">Hey there! You need assistance with anything?</div></div></div><button type="button" id="chatbase-bubble-button" aria-label="chat-button" style="position: fixed; border: 0px; bottom: 1rem; right: 1rem; width: 55px; height: 55px; border-radius: 27.5px; background-color: rgb(243, 255, 168); box-shadow: rgba(0, 0, 0, 0.2) 0px 4px 8px 0px; cursor: pointer; z-index: 2147483645; transition: 0.2s ease-in-out; left: unset;"><div style="display: flex; align-items: center; justify-content: center; width: 100%; height: 100%; z-index: 2147483646;"><img src="./Thymosin Alpha-1 - Peptide Standard_files/bV4iIfaGa67MbMybykThp.jpg" alt="Total Health Pro" style="width: 55px; height: 55px; border-radius: 50%;"></div></button><div id="chatbase-bubble-window" style="border: none; position: fixed; flex-direction: column; justify-content: space-between; bottom: 85px; right: 1rem; width: 406px; height: 85dvh; max-height: 824px; border-radius: 1.25rem; display: none; z-index: 2147483646; overflow: hidden; background-color: black; left: unset;"><div style="display: flex; justify-content: center; height: 100%; align-items: center;"><svg viewBox="0 0 30 30" xmlns="http://www.w3.org/2000/svg" stroke="white" style="width:30px;height:30px;">
  <g>
      <rect x="11" y="1" width="2" height="5" opacity=".14"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(30 12 12)" opacity=".29"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(60 12 12)" opacity=".43"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(90 12 12)" opacity=".57"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(120 12 12)" opacity=".71"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(150 12 12)" opacity=".86"></rect>
      <rect x="11" y="1" width="1" height="5" transform="rotate(180 12 12)"></rect>
      <animatetransform attributeName="transform" type="rotate" calcMode="discrete" dur="0.75s" values="0 12 12;30 12 12;60 12 12;90 12 12;120 12 12;150 12 12;180 12 12;210 12 12;240 12 12;270 12 12;300 12 12;330 12 12;360 12 12" repeatCount="indefinite"></animatetransform>
  </g>
</svg></div><iframe title="Total Health Pro" style="height: 100%; width: 100%; border: none; display: none;" src="./Thymosin Alpha-1 - Peptide Standard_files/saved_resource(1).html"></iframe></div></body></html>